EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity

Patrycja M Forster iD, Alexandra Preußer iD, Hiroshi Yano iD, Divija Deshpande iD, Wen Zhang iD, Anita Kowalczyk iD, Laura Velleman iD, Magdalena O Dubik iD, Jazib Uddin iD, Elizabeth R Emanuel iD, Pierre S Leclère iD, Richard Mertens iD und 7 weitere

Journal of Experimental Medicine · 04.05.2026 · 223 (5)

DOI: 10.1084/jem.20250781 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Experimental Medicine, online erschienen am 31.03.2026. Verfasst von Patrycja M Forster und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin an…. Hauptthemen laut MEDLINE: Positive Regulatory Domain I-Binding Factor 1, Immunity, Innate, Alarmins, Lymphocytes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Research Council, German Research Foundation, Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Type 2 immunity has evolved to protect against worms but becomes harmful when activated during allergic inflammation. Group 2 innate lymphoid cells (ILC2s) drive type 2 responses by rapidly secreting IL-5 and IL-13. The alarmins, IL-25, IL-33, and TSLP activate ILC2s and are linked to allergic diseases. However, how alarmins connect to the transcriptional networks driving type 2 effector functions remains elusive. Here, we performed RNA sequencing of ILC2s deficient in IL-25, IL-33, or TSLP pathway and identified the transcription factor Blimp-1 as an IL-33–regulated gene in ILC2s. While Blimp-1 was dispensable for ILC2 development, this transcription factor was required for type 2 cytokine production, driving eosinophilia or promoting worm expulsion. Blimp-1 deficiency resulted in reduced IRF4 expression, while Irf4-deficient ILC2s showed diminished Blimp-1 and IL-33 receptor expression, revealing a reciprocal Blimp-1–IRF4 circuit downstream of the IL-33 receptor. These findings expose the Blimp-1–IRF4 axis as an alarmin-regulated transcriptional network controlling ILC2 effector functions required for type 2 immunity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Positive Regulatory Domain I-Binding Factor 1Immunity, InnateAlarminsLymphocytesAnimalsInterferon Regulatory FactorsMiceInterleukin-33Signal TransductionCytokinesInterferon Regulatory Factor-4InflammationMice, Knockout

Substanzen

Positive Regulatory Domain I-Binding Factor 1Prdm1 protein, mouseInterferon Regulatory FactorsInterleukin-33AlarminsCytokinesInterferon Regulatory Factor-4

Autor:innen und Institutionen

  • Department of Microbiology, Infectious Diseases and Immunology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University , New York, NY, USA.
  • Friedman Center for Nutrition and Inflammation, Weill Cornell Medicine, Cornell University , New York, NY, USA.
  • Allen Discovery Center for Neuroimmune Interactions, Weill Cornell Medicine, Cornell University , New York, NY, USA.
  • Division of Gastroenterology and Hepatology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
  • Immunology and Microbial Pathogenesis Program, Weill Cornell Medicine, Cornell University , New York, NY, USA.

ORCID-Profile: Patrycja M Forster, Alexandra Preußer, Hiroshi Yano, Divija Deshpande, Wen Zhang, Anita Kowalczyk, Laura Velleman, Magdalena O Dubik, Jazib Uddin, Elizabeth R Emanuel, Pierre S Leclère, Richard Mertens, Xuemei Gao, Michael Kofoed-Branzk, Anja E Hauser, Hans-Willi Mittrücker, Andreas Diefenbach, David Artis, Christoph S N Klose

Förderung

  • European Research Council
  • German Research Foundation
  • Lundbeck Foundation
  • Crohn's and Colitis Foundation Research Fellowship
  • Sanders Family
  • Rosanne H. Silbermann Foundation
  • Weill Cornell Medicine
  • US National Institutes of Health

Zitieren

APA

Forster, P. M., Preußer, A., Yano, H., Deshpande, D., Zhang, W., Kowalczyk, A., Velleman, L., Dubik, M. O., Uddin, J., Emanuel, E. R., Leclère, P. S., Mertens, R., Gao, X., Kofoed-Branzk, M., Hauser, A. E., Mittrücker, H. W., Diefenbach, A., Artis, D., & Klose, C. S. N. (2026). Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity. Journal of Experimental Medicine, 223(5). https://doi.org/10.1084/jem.20250781

Vancouver

Forster PM, Preußer A, Yano H, Deshpande D, Zhang W, Kowalczyk A, et al. Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity. Journal of Experimental Medicine. 2026;223(5). doi:10.1084/jem.20250781

BibTeX
@article{Forster2026,
  author = {Forster, Patrycja M and Preußer, Alexandra and Yano, Hiroshi and Deshpande, Divija and Zhang, Wen and Kowalczyk, Anita and Velleman, Laura and Dubik, Magdalena O and Uddin, Jazib and Emanuel, Elizabeth R and Leclère, Pierre S and Mertens, Richard and Gao, Xuemei and Kofoed-Branzk, Michael and Hauser, Anja E and Mittrücker, Hans-Willi and Diefenbach, Andreas and Artis, David and Klose, Christoph S N},
  title = {Blimp-1 integrates alarmin signals in ILC2s and drives proinflammatory functions required for type 2 immunity},
  journal = {Journal of Experimental Medicine},
  year = {2026},
  volume = {223},
  number = {5},
  doi = {10.1084/jem.20250781}
}
Kostenlos starten →